UPDATE: Congress on Track to Reauthorize the SBIR and STTR Programs
Update on Biden’s $2-Billion Biotechnology Boost
SBIR/STTR Programs Could Expire Sept. 30
Biden Establishes National Biotechnology and Biomanufacturing Initiative with Executive Order
Is Non-Dilutive Funding the Key to Extending Runway in Biopharma and Biotech?
How Non-Dilutive Funding Leads to Equity Investment: The Story of Enalare
Webinar: $7+ Billion in Cancer Research Funding Opportunities 2022
Cancer Research in 2022: More than $7 Billion in Funding Opportunities
$130 Million in Funding Opportunities from PRCRP
PRCRP Priorities for Fiscal Year 2022
CDMRP Funding Opportunities 2022
ALS Research Funding Opportunities from CDMRP in 2022
Recent Posts
BioFuture – October 4-6, 2023 NYCMay 31, 2023 - 4:30 pm
RNA Leaders USA Congress – Boston, MA 6-7, 2023May 17, 2023 - 8:24 am
Peer Reviewed Cancer Research Program (PRCRP)April 13, 2023 - 8:18 am
19th Annual Anglonordic Life Science Conference – April 20, 2023 – LondonApril 2, 2023 - 8:53 am
FreeMind supports MedFIT 2023! October 10th, Strasbourg, FranceMarch 30, 2023 - 7:38 am